ESCO TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ESCO TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	571	686	772	726	730	715	858	856	919	1,095
Cost of revenue	351	437	420	438	458	445	525	503	531	634
Gross profit	221	249	352	288	272	270	332	353	389	461
Research and development	12.2	14	10.9	12.1	13.3	15.4	12.3	13	12	23
Selling, general and administrative	131	148	153	163	159	168	195	203	208	235
Operating income								119	146	170
Interest expense				8.1	6.7	2.2	4.9	8.77	15.2	17.5
Pre-tax income	68.4	80.2	81.1	97.9	36.4	80.7	106	110	131	153
Income tax	22.5	26.5	-5.17	20.4	13.5	17.2	24.1	24.7	28.3	36.6
Income from continuing operations	45.9	53.7	86.3	77.5	22.9	63.5	82.3	85.7	103	116
Net income	45.9	53.7	92.1	81	99.4	63.5	82.3	92.5	102	299
EBITDA								167	198	245
EPS, basic	1.78	2.08	3.56	3.12	3.82	2.44	3.17	3.59	3.95	11.59
EPS, diluted	1.77	2.07	3.54	3.10	3.81	2.42	3.16	3.58	3.94	11.55
Shares, basic (weighted)	25.8	25.8	25.9	25.9	26	26	25.9	25.8	25.8	25.8
Shares, diluted (weighted)	26	26	26.1	26.1	26.1	26.2	26.1	25.9	25.9	25.9
Dividend per share	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	53.8	45.5	30.5	61.8	52.6	56.2	97.7	41.9	66	101
Receivables	121	161	164	159	144	146	165	189	222	254
Inventory	106	125	135	125	135	147	162	184	195	218
Other current assets	13.9	14.9	13.4	14.2	17.1	22.7	22.7	18	21	25.1
Total current assets	323	393	396	495	443	466	573	581	669	689
Property, plant and equipment	92.4	133	135	128	140	154	156	155	149	172
Lease right-of-use assets					21.4	31.8	29.2	39.8	37.5	47.7
Goodwill	324	378	362	390	408	505	493	493	530	762
Intangible assets	232	351	345	382	347	409	394	392	404	724
Other non-current assets	7.11	5.89	7.14	4.45	10.9	11	9.54	11.5	13.8	15.8
Total assets	978	1,260	1,265	1,467	1,370	1,577	1,654	1,683	1,839	2,410
Accounts payable	42.1	54.8	63	63.8	50.5	56.7	78.7	87	88.9	96.5
Deferred revenue	27.2	28.6	49	81.2	101	106	125	112	80.8	217
Short-term debt	20	20	20	20	22.4	20	20	20	20	20
Total current liabilities	158	195	201	252	255	275	318	315	350	508
Long-term debt	90	255	200	265	40	134	133	82	102	166
Lease liabilities					16.8	28	24.9	36.6	34.8	44.4
Other non-current liabilities	5.78	22	24.1	36.3	38.2	47.1	48.3	43.3	39.3	38.6
Total liabilities	363	589	506	640	411	558	606	552	601	870
Total debt	110	275	220	285	62.4	154	153	102	122	186
Paid-in capital	291	290	291	292	294	298	302	305	312	316
Retained earnings	471	517	607	685	776	831	905	989	1,083	1,374
Treasury stock	-108	-108	-107	-107	-107	-107	-127	-139	-147	-147
Other comprehensive income	-39.3	-27.3	-31.5	-44	-3.66	-2.16	-31.8	-24	-10.8	-2.47
Shareholders' equity	615	672	759	826	959	1,020	1,048	1,131	1,237	1,541
Total equity	615	672	759	826	959	1,020	1,048	1,131	1,237	1,541
Total liabilities and equity	978	1,260	1,265	1,467	1,370	1,577	1,654	1,683	1,839	2,410

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	45.9	53.7	92.1	81	99.4	63.5	82.3	92.5	102	299
Depreciation and amortization	23.6	32.2	33.7	36	41.3	42	48.3	47.7	52.2	75
Stock-based compensation	4.7	5.44	5.03	5.09	5.55	6.91	7.32	8.91	8.6	10.7
Deferred income tax	-2.99	1.36	-21	0.06	-2.79	-3.04	8.95	-5.46	-8.39	-11
Change in receivables	-9.09	-23.6	-0.34	-8.72	14.6	11.3	-17.7	-31.4	-31.6	-8.34
Change in inventory	1.1	3.96	-9.44	7.11	-10.3	0.61	-13.8	-16.3	-24.4	-5.14
Change in payables	-1.95	8.74	7.93	10.7	-13.3	-0.69	22	5.11	11.5	-2.19
Cash from operations	73.9	67.3	93.3	105	82.3	123	135	76.9	128	242
Capital expenditures	-13.8	-29.7	-15.2	-24.2	-32.1	-26.7	-32.1	-19.7	-28.3	-36.3
Acquisitions	-82.1	-199	-9.81	-95.8		-169	-10.9	-17.7	-56.4	-472
Cash from investing	-105	-234	-41.6	-125	141	-202	-55.9	-52.5	-105	-256
Debt issued	140	257	55	130	12.4	216	100	103	217	661
Debt repaid	-80	-92	-110	-65	-235	-124	-101	-154	-197	-597
Share buybacks	-4.3	0	0				-19.9	-12.4	-8
Dividends paid	-8.25	-8.26	-8.28	-8.3	-8.32	-8.34	-8.27	-8.25	-8.25	-8.26
Cash from financing	46.2	157	-68.3	49.8	-236	81.5	-32.1	-78.3	-0.77	49.5
Exchange rate effect	-1.1	1.46	1.59	1.56	3.74	1.5
Net change in cash	14.4	-8.31	-15	31.3	-9.25	3.67	41.5	-55.9	24.1	35.4
Free cash flow	60	37.6	78	80.9	50.2	96.4	103	57.2	99.3	206
Interest paid	1.36	3.73	8.54	8.08	5.87	0.59	2.84	8.66	14.5	17.4
Income taxes paid	1.36	3.73	8.79	26.1	37.7	26.1	9.86	30.2	38	50

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $268.09 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	42.0%	Gross profit / revenue.
Pre-tax margin	13.9%	Pre-tax income / revenue.
Net margin	24.4%	Net income / revenue.
FCF margin	16.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.9%	Cash from operations / revenue.
Effective tax rate	22.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	19.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	13.0%	Net income / average total assets.
SG&A / revenue	20.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	8.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	19.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	8.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	18.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	11.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	16.5%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	23.7%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	193.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	53.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	24.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	193.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	54.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	24.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	89.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	21.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	24.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	107.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	25.8%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	32.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	24.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	13.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	31.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	13.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.38x	Current assets / current liabilities.
Quick ratio	0.62x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.13x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.05x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	3.5%	Total debt / total assets.
Liabilities / assets	33.2%	Total liabilities / total assets.
Net debt	$11.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$208.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	58.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$192.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.53x	Revenue / average total assets.
Fixed asset turnover	7.36x	Revenue / average property, plant and equipment.
Inventory turnover	3.11x	Cost of revenue / average inventory.
Days inventory	117 days	365 x average inventory / cost of revenue.
Receivables turnover	4.83x	Revenue / average receivables.
Days sales outstanding	76 days	365 x average receivables / revenue.
Days payables	57 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	136 days	Days inventory + days sales outstanding - days payables.
FCF conversion	65.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	15.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$12.12	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$49.68	Revenue / diluted weighted shares.
FCF per share	$7.98	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.39	Cash from operations / diluted weighted shares.
Book value per share	$62.25	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.41	Tangible book value / shares outstanding.
Cash per share	$2.82	(Cash + short-term investments) / shares outstanding.
Payout ratio	2.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	4.0%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$6.95B	Share price x shares outstanding.
Enterprise value	$6.96B	Market cap + total debt - cash - short-term investments.
P/E	22.1x	Market cap / net income. Only when net income is positive.
P/S	5.38x	Market cap / revenue.
P/B	4.29x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	36.1x	Market cap / tangible book value, when positive.
P/FCF	33.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	28.5x	Market cap / cash from operations, when positive.
EV/Sales	5.39x	Enterprise value / revenue.
EV/FCF	33.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.0%	Free cash flow / market cap.
Earnings yield	4.5%	Net income / market cap (the inverse of P/E).
Dividend yield	0.1%	Dividends paid over the period / market cap.
Shareholder yield	0.1%	(Dividends paid + share buybacks) / market cap.
PEG	0.41x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ESCO TECHNOLOGIES INC's revenue in fiscal 2025?

ESCO TECHNOLOGIES INC reported revenue of $1.10B for fiscal 2025, 19.2% higher than the year before.

Was ESCO TECHNOLOGIES INC profitable in fiscal 2025?

Yes. Net income was $299.2M, a net margin of 27.3%.

How much free cash flow did ESCO TECHNOLOGIES INC generate in fiscal 2025?

Cash from operations of $241.9M minus capital expenditures of $36.3M left free cash flow of $205.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ESCO TECHNOLOGIES INC